Yanchun Peng

7PUBLICATIONS
73CO-AUTHORS
Tumour immunologyMedical virologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 13, 2026
The challenge and promise of studying human antigen-specific T cells.

|Oct 01, 2025
Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19.

Guihai Liu, Elie Antoun, Anastasia Fries

|Sep 22, 2023
Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2.

Elie Antoun, Yanchun Peng, Tao Dong

|Sep 04, 2023
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.

Qi Chen, Adeline Chia, Shou Kit Hang

|Jun 30, 2023
HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation.

Hongbing Yang, Hong Sun, Simon Brackenridge

|Jun 17, 2022
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.

Pablo F Céspedes, Ashwin Jainarayanan, Lola Fernández-Messina

Pageof 2

Frequent Collaborators

4 joint publications

Tao Dong

3 joint publications

Alexander J Mentzer

3 joint publications

Peter A C Wing

2 joint publications

Julian C Knight